Annual report pursuant to Section 13 and 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.21.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2020
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of calculation of weighted average dilutive common shares

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

 

 

 

 

 

 

 

    

For the Years Ended

 

 

December 31, 

 

    

2020

    

2019

Stock options

 

118,412

 

93,967

Warrants [1]

 

7,403,722

 

1,138,556

Convertible notes [2]

 

 —

 

20,072

 

 

7,522,134

 

1,252,595


[1] Includes shares underlying warrants issued during the year ended December 31, 2019 that are exercisable into units consisting of an aggregate of (i) 1,235,977 shares of common stock and (ii) five-year warrants to purchase 1,235,977 shares of common stock at an exercise price of $5.50 per share. See Note 6 – Notes Payable – Convertible Notes Payable – Subordinated Offering for additional details.

[2] Excludes shares issuable upon conversion of the Senior and Junior Notes. See Note 6 — Notes Payable for additional details.